Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: CHR174
MIFTS: 45

Christianson Syndrome

Categories: Genetic diseases, Mental diseases, Neuronal diseases, Rare diseases
Genes Variations Tissues Related diseases Publications Symptoms & Phenotypes
Sources

Aliases & Classifications for Christianson Syndrome

About this section

MalaCards integrated aliases for Christianson Syndrome:

Name: Christianson Syndrome 12 24 52 25 36 29 6 15
X-Linked Intellectual Disability-Craniofacial Dysmorphism-Epilepsy-Ophthalmoplegia-Cerebellar Atrophy Syndrome 12 52
Mental Retardation, X-Linked, Syndromic, Christianson Type 43 71
X-Linked Intellectual Disability, South African Type 12 52
X-Linked Angelman-Like Syndrome 12 52
X-Linked Intellectual Disability - Craniofacial Dysmorphism - Epilepsy - Ophthalmoplegia - Cerebellar Atrophy 52
Intellectual Disability Microcephaly Epilepsy and Ataxia Syndrome 52
Mental Retardation, Microcephaly, Epilepsy, and Ataxia Syndrome 12
Intellectual Disability X-Linked Syndromic Christianson Type 52
Mental Retardation, X-Linked Syndromic, Christianson Type 12
Intellectual Deficit, X-Linked, South African Type 25
Mental Retardation X-Linked, South African Type 43
Angelman-Like Syndrome, X-Linked 25
Angelman-Like Syndrome X-Linked 52
Mrxs Christianson 52
Mrxsch 12

Characteristics:

HPO:

31
christianson syndrome:
Clinical modifier death in early adulthood


Classifications:

MalaCards categories:
Global: Rare diseases Genetic diseases
Anatomical: Mental diseases Neuronal diseases
See all MalaCards categories (disease lists)


Sources

Summaries for Christianson Syndrome

About this section
Genetics Home Reference : 25 Christianson syndrome is a disorder that primarily affects the nervous system. This condition becomes apparent in infancy. Its characteristic features include delayed development, intellectual disability, an inability to speak, problems with balance and coordination (ataxia), and difficulty standing or walking. Individuals who do learn to walk lose the ability in childhood. Most affected children also have recurrent seizures (epilepsy), beginning between ages 1 and 2. Other features seen in many people with Christianson syndrome include a small head size (microcephaly); a long, narrow face with prominent nose, jaw, and ears; an open mouth and uncontrolled drooling; and abnormal eye movements. Affected children often have a happy demeanor with frequent smiling and spontaneous laughter.

MalaCards based summary : Christianson Syndrome, also known as x-linked intellectual disability-craniofacial dysmorphism-epilepsy-ophthalmoplegia-cerebellar atrophy syndrome, is related to angelman syndrome and alacrima, achalasia, and mental retardation syndrome, and has symptoms including ataxia, ophthalmoplegia and sleep disturbances. An important gene associated with Christianson Syndrome is SLC9A6 (Solute Carrier Family 9 Member A6). Affiliated tissues include eye, cerebellum and brain, and related phenotypes are developmental regression and macrotia

Disease Ontology : 12 A syndromic X-linked intellectual disability characterized by severe developmental delay, intellectual disability, microcephaly, impaired speech, ataxia, hypotonia and early-onset seizures that has material basis in mutation in the SLC9A6 gene on chromosome Xq26.

NIH Rare Diseases : 52 Christianson syndrome is an X-linked syndrome associated with intellectual disability , microcephaly , seizures , ataxia , and absent speech. Many individuals with this condition have a happy demeanor with frequent smiling and unprovoked laughter, similar to those with Angelman syndrome . Christianson syndrome is caused by mutations in the SLC9A6 gene , which is located within the q24-q27 interval of the X chromosome . There appears to be a range of phenotypes in carrier females, from intellectual disability to absence of symptoms.

KEGG : 36 Christianson syndrome (CS) is a rare, X-linked mental retardation syndrome, caused by mutations in SLC9A6. CS is characterized by severe intellectual disability, microcephaly, epilepsy, ataxia, and absent speech. The clinical phenotype of CS mimics Angelman syndrome and CS was initially called X-linked Angelman-like syndrome.

Wikipedia : 74 Christianson syndrome is an X linked syndrome associated with intellectual disability, microcephaly,... more...

GeneReviews: NBK475801
Sources

Related Diseases for Christianson Syndrome

About this section

Diseases related to Christianson Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 57)
# Related Disease Score Top Affiliating Genes
1 angelman syndrome 29.9 UBE3A SLC9A7 SLC9A6 MECP2 CDKL5
2 alacrima, achalasia, and mental retardation syndrome 29.8 UBE3A SLC9A6 MECP2 EHMT1
3 microcephaly 29.7 SLC9A6 MECP2 MBD5 FOXG1
4 west syndrome 28.6 SLC9A7 SLC9A6 NTRK2 MECP2 FOXG1 CDKL5
5 pervasive developmental disorder 28.4 UBE3A SLC9A9 SLC9A6 NTRK2 MECP2 MBD5
6 mental retardation, x-linked, syndromic, christianson type 12.1
7 ataxia and polyneuropathy, adult-onset 10.4
8 epileptic encephalopathy, early infantile, 4 10.3 SLC9A7 SLC9A6
9 epileptic encephalopathy, childhood-onset 10.3 SLC9A7 SLC9A6
10 landau-kleffner syndrome 10.2 CNKSR2 CDKL5
11 neuroaxonal dystrophy 10.2
12 corticobasal degeneration 10.2
13 lysosomal disease 10.2
14 kearns-sayre syndrome 10.2
15 status epilepticus 10.2
16 encephalopathy 10.2
17 hypotonia 10.2
18 mental retardation, x-linked, with cerebellar hypoplasia and distinctive facial appearance 10.1 SLC9A7 SLC9A6
19 mecp2 disorders 10.0 MECP2 FOXG1
20 gastroesophageal reflux 10.0
21 myopathy, x-linked, with postural muscle atrophy 10.0
22 striatal degeneration, autosomal dominant 2 10.0
23 pain sensitivity quantitative trait locus 1 10.0
24 autism spectrum disorder 10.0
25 scoliosis 10.0
26 scapuloperoneal myopathy 10.0
27 reducing body myopathy 10.0
28 neuroretinitis 10.0
29 emery-dreifuss muscular dystrophy 10.0
30 retinitis 10.0
31 mutism 10.0
32 myopathy 10.0
33 retinal degeneration 10.0
34 learning disability 10.0
35 muscular dystrophy 10.0
36 dysphagia 10.0
37 spasticity 10.0
38 seizure disorder 9.9 MECP2 CDKL5
39 gait apraxia 9.9 MECP2 FOXG1 CDKL5
40 infancy electroclinical syndrome 9.8 MECP2 CDKL5 ALG13
41 syndromic x-linked intellectual disability 9.8 SLC9A7 SLC9A6 MECP2 CNKSR2
42 specific developmental disorder 9.7 UBE3A MECP2 CDKL5
43 non-syndromic x-linked intellectual disability 9.7 SLC9A7 MECP2 CNKSR2 ALG13
44 lubs x-linked mental retardation syndrome 9.7 UBE3A MECP2 FOXG1 CDKL5
45 bruxism 9.7 UBE3A MECP2 FOXG1 CDKL5
46 syndromic intellectual disability 9.7 SLC9A7 SLC9A6 MECP2 KANSL1
47 lennox-gastaut syndrome 9.6 MECP2 FOXG1 CDKL5 ALG13
48 rett syndrome 9.5 UBE3A MECP2 FOXG1 CDKL5
49 congenital nervous system abnormality 9.5 UBE3A SLC9A6 MECP2 FOXG1 CDKL5
50 sotos syndrome 1 9.3 UBE3A MECP2 MBD5 EHMT1

Graphical network of the top 20 diseases related to Christianson Syndrome:



Diseases related to Christianson Syndrome
Sources

Symptoms & Phenotypes for Christianson Syndrome

About this section

Human phenotypes related to Christianson Syndrome:

31 (show all 39)
# Description HPO Frequency HPO Source Accession
1 developmental regression 31 hallmark (90%) HP:0002376
2 macrotia 31 hallmark (90%) HP:0000400
3 thick eyebrow 31 hallmark (90%) HP:0000574
4 strabismus 31 hallmark (90%) HP:0000486
5 severe global developmental delay 31 hallmark (90%) HP:0011344
6 absent speech 31 hallmark (90%) HP:0001344
7 cachexia 31 hallmark (90%) HP:0004326
8 aplasia/hypoplasia of the cerebellum 31 hallmark (90%) HP:0007360
9 generalized-onset seizure 31 hallmark (90%) HP:0002197
10 narrow face 31 hallmark (90%) HP:0000275
11 long face 31 hallmark (90%) HP:0000276
12 intellectual disability, profound 31 hallmark (90%) HP:0002187
13 truncal ataxia 31 hallmark (90%) HP:0002078
14 cerebellar atrophy 31 hallmark (90%) HP:0001272
15 neuronal loss in central nervous system 31 hallmark (90%) HP:0002529
16 pectus excavatum 31 frequent (33%) HP:0000767
17 nystagmus 31 frequent (33%) HP:0000639
18 dysphagia 31 frequent (33%) HP:0002015
19 cerebral cortical atrophy 31 frequent (33%) HP:0002120
20 microcephaly 31 frequent (33%) HP:0000252
21 gastroesophageal reflux 31 frequent (33%) HP:0002020
22 feeding difficulties in infancy 31 frequent (33%) HP:0008872
23 stereotypy 31 frequent (33%) HP:0000733
24 autism 31 frequent (33%) HP:0000717
25 gait ataxia 31 frequent (33%) HP:0002066
26 dystonia 31 frequent (33%) HP:0001332
27 ventriculomegaly 31 frequent (33%) HP:0002119
28 ophthalmoplegia 31 frequent (33%) HP:0000602
29 adducted thumb 31 frequent (33%) HP:0001181
30 aplasia/hypoplasia of the corpus callosum 31 frequent (33%) HP:0007370
31 conspicuously happy disposition 31 frequent (33%) HP:0100024
32 mutism 31 frequent (33%) HP:0002300
33 inappropriate laughter 31 frequent (33%) HP:0000748
34 mandibular prognathia 31 occasional (7.5%) HP:0000303
35 arthrogryposis multiplex congenita 31 occasional (7.5%) HP:0002804
36 decreased muscle mass 31 occasional (7.5%) HP:0003199
37 joint hyperflexibility 31 occasional (7.5%) HP:0005692
38 deeply set eye 31 occasional (7.5%) HP:0000490
39 abnormality of the nose 31 occasional (7.5%) HP:0000366

UMLS symptoms related to Christianson Syndrome:


ataxia, ophthalmoplegia, sleep disturbances, ataxia, truncal

MGI Mouse Phenotypes related to Christianson Syndrome:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.97 CDKL5 CHP1 CNKSR2 EHMT1 FOXG1 KANSL1
2 homeostasis/metabolism MP:0005376 9.7 EHMT1 FOXG1 KANSL1 MBD5 MECP2 NTRK2
3 nervous system MP:0003631 9.4 CDKL5 CHP1 EHMT1 FOXG1 KANSL1 MBD5
Sources

Drugs & Therapeutics for Christianson Syndrome

About this section

Search Clinical Trials , NIH Clinical Center for Christianson Syndrome

Cochrane evidence based reviews: mental retardation, x-linked, syndromic, christianson type

Sources

Genetic Tests for Christianson Syndrome

About this section

Genetic tests related to Christianson Syndrome:

# Genetic test Affiliating Genes
1 Christianson Syndrome 29 SLC9A6
Sources

Anatomical Context for Christianson Syndrome

About this section

MalaCards organs/tissues related to Christianson Syndrome:

40
Eye, Cerebellum, Brain
Sources

Publications for Christianson Syndrome

About this section

Articles related to Christianson Syndrome:

(show all 42)
# Title Authors PMID Year
1
A new family with an SLC9A6 mutation expanding the phenotypic spectrum of Christianson syndrome. 24 61
27256868 2016
2
The expanding phenotypic spectrum of female SLC9A6 mutation carriers: a case series and review of the literature. 61 24
27142213 2016
3
Genetic and phenotypic diversity of NHE6 mutations in Christianson syndrome. 61 24
25044251 2014
4
A novel mutation in the endosomal Na+/H+ exchanger NHE6 (SLC9A6) causes Christianson syndrome with electrical status epilepticus during slow-wave sleep (ESES). 61 24
24630051 2014
5
Christianson syndrome protein NHE6 modulates TrkB endosomal signaling required for neuronal circuit development. 24 61
24035762 2013
6
Novel SLC9A6 mutations in two families with Christianson syndrome. 24 61
22931061 2013
7
Novel mutation in SLC9A6 gene in a patient with Christianson syndrome and retinitis pigmentosum. 61 24
22541666 2013
8
Christianson syndrome in a patient with an interstitial Xq26.3 deletion. 61 24
21932316 2011
9
Natural history of Christianson syndrome. 61 24
20949524 2010
10
SLC9A6 mutations cause X-linked mental retardation, microcephaly, epilepsy, and ataxia, a phenotype mimicking Angelman syndrome. 24 61
18342287 2008
11
Improving diagnosis and broadening the phenotypes in early-onset seizure and severe developmental delay disorders through gene panel analysis. 24
26993267 2016
12
Successful Treatment of Electrographic Status Epilepticus of Sleep With Felbamate in a Patient With SLC9A6 Mutation. 24
26421989 2015
13
Next-generation sequencing in X-linked intellectual disability. 24
25649377 2015
14
Na+/H+ exchanger isoform 6 (NHE6/SLC9A6) is involved in clathrin-dependent endocytosis of transferrin. 24
21881004 2011
15
A loss-of-function mutation in the SLC9A6 gene causes X-linked mental retardation resembling Angelman syndrome. 24
21812100 2011
16
Organellar Na+/H+ exchangers: novel players in organelle pH regulation and their emerging functions. 24
21171650 2011
17
A mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau deposition. 24
20395263 2010
18
Mutation in the SLC9A6 gene is not a frequent cause of sporadic Angelman-like syndrome. 24
19471312 2009
19
A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation. 24
19377476 2009
20
Four Na+/H+ exchanger isoforms are distributed to Golgi and post-Golgi compartments and are involved in organelle pH regulation. 24
15522866 2005
21
X linked severe mental retardation, craniofacial dysmorphology, epilepsy, ophthalmoplegia, and cerebellar atrophy in a large South African kindred is localised to Xq24-q27. 24
10528855 1999
22
Pathobiology of Christianson syndrome: Linking disrupted endosomal-lysosomal function with intellectual disability and sensory impairments. 61
29772390 2019
23
Functional Assessment In Vivo of the Mouse Homolog of the Human Ala-9-Ser NHE6 Variant. 61
31676550 2019
24
Xq26 duplications lead to undergrowth or overgrowth via competing pathways including GPC3/GPC4. 61
31583675 2019
25
A Christianson syndrome-linked deletion mutation (Δ287ES288) in SLC9A6 impairs hippocampal neuronal plasticity. 61
31175985 2019
26
Complex Neurological Phenotype in Female Carriers of NHE6 Mutations. 61
31192222 2019
27
A novel splicing mutation in SLC9A6 in a boy with Christianson syndrome. 61
30937176 2019
28
A potential gain-of-function variant of SLC9A6 leads to endosomal alkalinization and neuronal atrophy associated with Christianson Syndrome. 61
30296617 2019
29
Electrical status epilepticus in sleep, a constitutive feature of Christianson syndrome? 61
30126759 2018
30
Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH. 61
29946028 2018
31
The Na+(K+)/H+ exchanger Nhx1 controls multivesicular body-vacuolar lysosome fusion. 61
29212874 2018
32
Christianson Syndrome 61
29334451 2018
33
Syndrome of X linked intellectual disability, epilepsy, progressive brain atrophy and large head associated with SLC9A6 mutation. 61
29275387 2017
34
Mixed Neurodevelopmental and Neurodegenerative Pathology in Nhe6-Null Mouse Model of Christianson Syndrome. 61
29349289 2017
35
A Christianson syndrome-linked deletion mutation (∆(287)ES(288)) in SLC9A6 disrupts recycling endosomal function and elicits neurodegeneration and cell death. 61
27590723 2016
36
Exonic deletion of SLC9A9 in autism with epilepsy. 61
27123481 2016
37
X-linked Christianson syndrome: heterozygous female Slc9a6 knockout mice develop mosaic neuropathological changes and related behavioral abnormalities. 61
26515654 2016
38
Christianson syndrome: spectrum of neuroimaging findings. 61
24285247 2014
39
Genetic disorders associated with postnatal microcephaly. 61
24839169 2014
40
If not Angelman, what is it? A review of Angelman-like syndromes. 61
24779060 2014
41
Inaugural Christianson Syndrome Association conference: families meeting for the first time. 61
25273398 2014
42
X-linked Angelman-like syndrome caused by Slc9a6 knockout in mice exhibits evidence of endosomal-lysosomal dysfunction. 61
21964919 2011
Sources

Variations for Christianson Syndrome

About this section

ClinVar genetic disease variations for Christianson Syndrome:

6 (show top 50) (show all 51) ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎
# Gene Name Type Significance ClinVarId dbSNP ID GRCh37 Pos GRCh38 Pos
1 SLC9A6 NM_001042537.1(SLC9A6):c.1012_1020del (p.Gly338_Ala340del)deletion Pathogenic 29949 rs398122849 X:135092713-135092721 X:136010554-136010562
2 SLC9A6 NM_001042537.1(SLC9A6):c.1639G>T (p.Glu547Ter)SNV Pathogenic 92121 rs398123003 X:135112313-135112313 X:136030154-136030154
3 SLC9A6 NM_001042537:c.916delCundetermined variant Pathogenic 246605
4 SLC9A6 NM_001042537.1(SLC9A6):c.882del (p.Ala295fs)deletion Pathogenic 375585 rs1057519394 X:135084355-135084355 X:136002196-136002196
5 SLC9A6 NM_001042537.1(SLC9A6):c.1463-1G>ASNV Pathogenic 625179 X:135106488-135106488 X:136024329-136024329
6 SLC9A6 NM_006359.3(SLC9A6):c.478_479AT[1] (p.Phe161fs)short repeat Pathogenic 627623 X:135080315-135080316 X:135998156-135998157
7 SLC9A6 NM_001042537.1(SLC9A6):c.2078T>G (p.Leu693Ter)SNV Pathogenic 159932 rs587784399 X:135126855-135126855 X:136044696-136044696
8 SLC9A6 NM_001042537.1(SLC9A6):c.608_609del (p.His203fs)deletion Pathogenic 11479 rs730882188 X:135080645-135080646 X:135998486-135998487
9 SLC9A6 NM_001042537.1(SLC9A6):c.603+3_603+4delinsCCindel Pathogenic 11478 rs730882187 X:135080347-135080348 X:135998188-135998189
10 SLC9A6 NM_001042537.1(SLC9A6):c.1498C>T (p.Arg500Ter)SNV Pathogenic 11477 rs122461162 X:135106524-135106524 X:136024365-136024365
11 SLC9A6 NM_001042537.1(SLC9A6):c.860_865del (p.Glu287_Ser288del)deletion Pathogenic 11476 rs886037619 X:135084333-135084338 X:136002174-136002179
12 SLC9A6 NM_001042537.1(SLC9A6):c.183del (p.Lys61fs)deletion Pathogenic 159931 rs587784398 X:135067844-135067844 X:135985685-135985685
13 SLC9A6 NM_001042537.1(SLC9A6):c.899+1G>ASNV Pathogenic/Likely pathogenic 432837 rs1556617455 X:135084373-135084373 X:136002214-136002214
14 SLC9A6 NM_001042537.1(SLC9A6):c.1472G>A (p.Gly491Asp)SNV Likely pathogenic 577815 rs1569525357 X:135106498-135106498 X:136024339-136024339
15 SLC9A6 NM_001042537.1(SLC9A6):c.1239G>A (p.Leu413=)SNV Conflicting interpretations of pathogenicity 469632 rs151178361 X:135098806-135098806 X:136016647-136016647
16 SLC9A6 NM_001042537.1(SLC9A6):c.171C>G (p.Ile57Met)SNV Conflicting interpretations of pathogenicity 379120 rs782296172 X:135067832-135067832 X:135985673-135985673
17 SLC9A6 NM_001042537.1(SLC9A6):c.526-9_526-5deldeletion Conflicting interpretations of pathogenicity 207248 rs796053290 X:135080258-135080262 X:135998099-135998103
18 SLC9A6 NM_001042537.1(SLC9A6):c.581A>G (p.Tyr194Cys)SNV Uncertain significance 469636 rs1556616834 X:135080322-135080322 X:135998163-135998163
19 SLC9A6 NM_001042537.1(SLC9A6):c.1584C>T (p.Gly528=)SNV Uncertain significance 469634 rs782370742 X:135106610-135106610 X:136024451-136024451
20 SLC9A6 NM_001042537.1(SLC9A6):c.1042G>A (p.Val348Met)SNV Uncertain significance 469638 rs1556618832 X:135095108-135095108 X:136012949-136012949
21 SLC9A6 NM_001042537.1(SLC9A6):c.7C>T (p.Arg3Trp)SNV Uncertain significance 657261 X:135067668-135067668 X:135985509-135985509
22 SLC9A6 NM_001042537.1(SLC9A6):c.227_244del (p.Ile76_Leu81del)deletion Uncertain significance 653174 X:135067881-135067898 X:135985729-135985746
23 SLC9A6 NM_001042537.1(SLC9A6):c.549T>G (p.Phe183Leu)SNV Uncertain significance 647660 X:135080290-135080290 X:135998131-135998131
24 SLC9A6 NM_001042537.1(SLC9A6):c.639A>G (p.Ala213=)SNV Uncertain significance 656614 X:135080676-135080676 X:135998517-135998517
25 SLC9A6 NM_001042537.1(SLC9A6):c.808A>G (p.Ile270Val)SNV Uncertain significance 646158 X:135084281-135084281 X:136002122-136002122
26 SLC9A6 NM_001042537.1(SLC9A6):c.715G>A (p.Val239Ile)SNV Uncertain significance 575064 rs1556616995 X:135081049-135081049 X:135998890-135998890
27 SLC9A6 NM_001042537.1(SLC9A6):c.362A>G (p.His121Arg)SNV Uncertain significance 409978 rs1060502675 X:135076981-135076981 X:135994822-135994822
28 SLC9A6 NM_001042537.1(SLC9A6):c.269T>C (p.Leu90Pro)SNV Uncertain significance 469635 rs1556614843 X:135067930-135067930 X:135985771-135985771
29 SLC9A6 NM_001042537.1(SLC9A6):c.1939A>G (p.Ser647Gly)SNV Uncertain significance 537363 rs558960349 X:135126716-135126716 X:136044557-136044557
30 SLC9A6 NM_001042537.1(SLC9A6):c.8G>T (p.Arg3Leu)SNV Uncertain significance 572609 X:135067669-135067669 X:135985510-135985510
31 SLC9A6 NM_001042537.1(SLC9A6):c.685A>G (p.Ile229Val)SNV Uncertain significance 159936 rs587784402 X:135081019-135081019 X:135998860-135998860
32 SLC9A6 NM_001042537.1(SLC9A6):c.412A>G (p.Ser138Gly)SNV Uncertain significance 159935 rs587784401 X:135077031-135077031 X:135994872-135994872
33 SLC9A6 NM_001042537.1(SLC9A6):c.367C>T (p.Pro123Ser)SNV Uncertain significance 159934 rs587784400 X:135076986-135076986 X:135994827-135994827
34 SLC9A6 NM_001042537.1(SLC9A6):c.672C>T (p.Phe224=)SNV Likely benign 469637 rs1423014570 X:135080709-135080709 X:135998550-135998550
35 SLC9A6 NM_001042537.1(SLC9A6):c.384T>C (p.Asn128=)SNV Likely benign 415902 rs782529317 X:135077003-135077003 X:135994844-135994844
36 SLC9A6 NM_001042537.1(SLC9A6):c.1320C>T (p.Val440=)SNV Likely benign 469633 rs1556619315 X:135098887-135098887 X:136016728-136016728
37 SLC9A6 NM_001042537.1(SLC9A6):c.1764G>A (p.Pro588=)SNV Likely benign 415903 rs1060504687 X:135122271-135122271 X:136040112-136040112
38 SLC9A6 NM_001042537.1(SLC9A6):c.1116C>G (p.Thr372=)SNV Likely benign 415901 rs1060504686 X:135095182-135095182 X:136013023-136013023
39 SLC9A6 NM_001042537.1(SLC9A6):c.1237-8C>TSNV Likely benign 415899 rs1060504684 X:135098796-135098796 X:136016637-136016637
40 SLC9A6 NM_001042537.1(SLC9A6):c.759A>G (p.Leu253=)SNV Likely benign 415900 rs1060504685 X:135081093-135081093 X:135998934-135998934
41 SLC9A6 NM_001042537.1(SLC9A6):c.1755C>T (p.Ser585=)SNV Benign/Likely benign 139209 rs2307131 X:135122262-135122262 X:136040103-136040103
42 SLC9A6 NM_001042537.1(SLC9A6):c.1703G>A (p.Arg568Gln)SNV Benign/Likely benign 139207 rs146263125 X:135115628-135115628 X:136033469-136033469
43 SLC9A6 NM_001042537.1(SLC9A6):c.153A>G (p.Arg51=)SNV Benign/Likely benign 389505 rs782090744 X:135067814-135067814 X:135985655-135985655
44 SLC9A6 NM_001042537.1(SLC9A6):c.25G>T (p.Ala9Ser)SNV Benign/Likely benign 159933 rs201523857 X:135067686-135067686 X:135985527-135985527
45 SLC9A6 NM_001042537.1(SLC9A6):c.1728-4G>ASNV Benign 139208 rs188072063 X:135122231-135122231 X:136040072-136040072
46 SLC9A6 NM_001042537.1(SLC9A6):c.1616+4A>GSNV Benign 95376 rs180727016 X:135106646-135106646 X:136024487-136024487
47 SLC9A6 NM_001042537.1(SLC9A6):c.630T>C (p.Ser210=)SNV Benign 139200 rs144316388 X:135080667-135080667 X:135998508-135998508
48 SLC9A6 NM_001042537.1(SLC9A6):c.900-6C>TSNV Benign 139201 rs17001258 X:135092595-135092595 X:136010436-136010436
49 SLC9A6 NM_001042537.1(SLC9A6):c.1185A>C (p.Ala395=)SNV Benign 139203 rs142049079 X:135095545-135095545 X:136013386-136013386
50 SLC9A6 NM_001042537.1(SLC9A6):c.1616+10A>GSNV Benign 139204 rs185533973 X:135106652-135106652 X:136024493-136024493
Sources

Expression for Christianson Syndrome

About this section
Search GEO for disease gene expression data for Christianson Syndrome.
Sources

Pathways for Christianson Syndrome

About this section
Sources

GO Terms for Christianson Syndrome

About this section

Cellular components related to Christianson Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cell GO:0005623 9.43 SLC9A9 SLC9A8 SLC9A7 SLC9A6 SLC9A1 CHP1
2 recycling endosome GO:0055037 8.8 SLC9A9 SLC9A7 SLC9A6

Biological processes related to Christianson Syndrome according to GeneCards Suite gene sharing:

(show all 16)
# Name GO ID Score Top Affiliating Genes
1 ion transport GO:0006811 9.95 SLC9A9 SLC9A8 SLC9A7 SLC9A6 SLC9A1
2 transmembrane transport GO:0055085 9.93 SLC9A9 SLC9A8 SLC9A7 SLC9A6 SLC9A1
3 potassium ion transmembrane transport GO:0071805 9.85 SLC9A9 SLC9A8 SLC9A7 SLC9A6 SLC9A1
4 sodium ion transport GO:0006814 9.83 SLC9A9 SLC9A8 SLC9A7 SLC9A6 SLC9A1
5 proton transmembrane transport GO:1902600 9.8 SLC9A9 SLC9A8 SLC9A7 SLC9A6 SLC9A1
6 sodium ion transmembrane transport GO:0035725 9.77 SLC9A9 SLC9A8 SLC9A7 SLC9A6 SLC9A1
7 cation transport GO:0006812 9.72 SLC9A9 SLC9A8 SLC9A7 SLC9A6 SLC9A1
8 histone methylation GO:0016571 9.56 MECP2 EHMT1
9 sodium ion import across plasma membrane GO:0098719 9.56 SLC9A9 SLC9A7 SLC9A6 SLC9A1
10 anion transmembrane transport GO:0098656 9.55 SLC9A9 SLC9A8 SLC9A7 SLC9A6 SLC9A1
11 hyaluronan catabolic process GO:0030214 9.52 SLC9A1 CHP1
12 cellular response to brain-derived neurotrophic factor stimulus GO:1990416 9.51 UBE3A NTRK2
13 cellular response to acidic pH GO:0071468 9.49 SLC9A1 CHP1
14 brain-derived neurotrophic factor receptor signaling pathway GO:0031547 9.48 SLC9A6 NTRK2
15 regulation of pH GO:0006885 9.35 SLC9A9 SLC9A8 SLC9A7 SLC9A6 SLC9A1
16 regulation of intracellular pH GO:0051453 9.1 SLC9A9 SLC9A8 SLC9A7 SLC9A6 SLC9A1 CHP1

Molecular functions related to Christianson Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 antiporter activity GO:0015297 9.65 SLC9A9 SLC9A8 SLC9A7 SLC9A6 SLC9A1
2 solute:proton antiporter activity GO:0015299 9.55 SLC9A9 SLC9A8 SLC9A7 SLC9A6 SLC9A1
3 sodium:proton antiporter activity GO:0015385 9.35 SLC9A9 SLC9A8 SLC9A7 SLC9A6 SLC9A1
4 potassium:proton antiporter activity GO:0015386 9.02 SLC9A9 SLC9A8 SLC9A7 SLC9A6 SLC9A1
Sources

Sources for Christianson Syndrome

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....